Janus Henderson Group PLC Mirum Pharmaceuticals, Inc. Transaction History
Janus Henderson Group PLC
- $182 Billion
- Q2 2024
A detailed history of Janus Henderson Group PLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 4,988,747 shares of MIRM stock, worth $196 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
4,988,747
Previous 2,767,210
80.28%
Holding current value
$196 Million
Previous $69.5 Million
145.37%
% of portfolio
0.09%
Previous 0.04%
Shares
6 transactions
Others Institutions Holding MIRM
# of Institutions
172Shares Held
54.2MCall Options Held
96.1KPut Options Held
54.8K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.5MShares$256 Million13.09% of portfolio
-
Bvf Inc San Francisco, CA4.37MShares$172 Million4.57% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.61MShares$142 Million2.18% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$127 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.45MShares$96.3 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.45B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...